Catalytic iron promotes LDL oxidation and atherosclerosis.

An objective, evidence-based assessment of the relationship between catalytic iron, low-density lipoprotein (LDL) oxidation, atherosclerosis, and vascular inflammation reveals strong scientific support for these pathological links.

Mechanistic explanations

• Fenton chemistry and lipid peroxidation: Catalytically active, labile iron ($Fe^{2+}$) is a potent driver of oxidative stress. Through Fenton and Fenton-like reactions, ferrous iron reacts with hydrogen peroxide and lipid hydroperoxides to generate highly reactive hydroxyl ($\bullet\text{OH}$), alkoxyl ($\text{LO}\bullet$), and peroxyl ($\text{LOO}\bullet$) radicals. These radicals abstract hydrogen atoms from polyunsaturated fatty acids (PUFAs), initiating and propagating a self-sustaining lipid peroxidation cascade.
• Generation of oxidized LDL (oxLDL): LDL particles are highly enriched with PUFAs, making them primary targets for iron-mediated oxidation. In microenvironments such as the acidic lysosome or the subendothelial space, catalytic iron drives the peroxidation of LDL lipids. This decomposition yields reactive aldehydes (like malondialdehyde and 4-hydroxynonenal) that covalently modify apolipoprotein B-100 (apoB-100), transforming native LDL into highly atherogenic oxLDL.
• Macrophage uptake and foam cell formation: Unlike native LDL, oxLDL is rapidly internalized by macrophage scavenger receptors (primarily CD36 and Scavenger Receptor-A) in a process that is not subject to negative feedback inhibition. This unregulated lipid uptake leads to massive intracellular cholesteryl ester accumulation, transforming macrophages into foam cells—the foundational cellular component of atherosclerotic plaques.
• Vascular inflammation cascade: oxLDL triggers endothelial dysfunction by decreasing nitric oxide bioavailability and upregulating adhesion molecules (such as VCAM-1, ICAM-1, and E-selectin) and chemokines that recruit circulating monocytes. Furthermore, oxLDL binding to scavenger receptors and lectin-like oxidized LDL receptor-1 (LOX-1) cooperates with toll-like receptors (like TLR4) to activate downstream inflammatory pathways, including the NLRP3 inflammasome, which releases pro-inflammatory cytokines like interleukin-1 beta ($\text{IL-1}\beta$).

Clinical and effectiveness evidence

• Clinical cohort correlations: Epidemiological and cohort studies have consistently linked elevated circulating levels of oxLDL to increased carotid intima-media thickness (CIMT), subclinical plaque progression, and a higher risk of acute coronary syndromes.
• Synergy with systemic inflammation: Clinical data show that the cardiovascular risk associated with elevated oxLDL is significantly pronounced when combined with systemic inflammatory markers, such as high-sensitivity C-reactive protein (hs-CRP), underscoring the dual roles of lipid oxidation and vascular inflammation in cardiovascular disease progression.

Bottom line

Catalytic iron acts as a fundamental initiator of lipid peroxidation and LDL oxidation via Fenton chemistry. The resulting oxLDL is a key driver of cardiovascular pathology, promoting vascular inflammation, endothelial activation, and unregulated macrophage lipid uptake to accelerate foam cell formation and atherosclerosis.